Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 41
- Medical
One Year Extension To France’s Medical Cannabis Trial Makes Its Way Through Parliament
As reported in NewsWeed.fr LAST month France’s Directorate General of Health (DGS) pushed ahead with plans to extend the country’s medical cannabis trial by a minimum of one year without waiting for the results of the trial to be submitted to parliament.
- Adult-Use
Promise of legal German market draws US and Canadian investment
EUROPEAN OPPORTUNITY Promise of legal German market draws US and Canadian investment The process to legalize adult-use cannabis in Germany has recently rekindled the interest of US and Canadian cannabis companies to invest in Europe, reports Forbes.
- Adult-Use
Venture Capitalists Investing In German Cannabis Market Need To ‘Look Beyond Decks And Focus On People And The Market Reality’
AS Germany edges steadily closer to launching an adult-use cannabis market, investment interest into what is already Europe’s largest medical cannabis market has grown in tandem.
- Adult-Use
US cannabis industry still face huge risks
RISKY BUSINESS US cannabis industry still face huge risks Insurance Business Magazine explores some of the top risks facing cannabis businesses in the US today.
- Medical
North Macedonian medical cannabis reaches German market
Cantourage is co-operating with Green Medicals Germany.
- Medical
Crowdfunder to raise funds for health economics analysis of cannabis on NHS
The crowdfunder has been launched by the UK’s Cannabis Industry Council (CIC).
- Medical
Panaxia and Neuraxpharm expand into Czech and Swiss markets
The pair will be expanding their co-operation through the distribution of medical cannabis products.
- Adult-Use
Cookies and Akanda: bringing premium cannabis genetics to Europe
Akanda CEO Tej Virk speaks to Cannabis Wealth about its new agreement to bring Cookies’ globally recognised genetics to the European market.
- Medical
UK Companies Warn Ban On Medical Cannabis Exports Will Damage Future Investment
AS Brains Bioceuticals unveiled a significant expansion of its UK production facilities, it has warned that any future investment is under threat unless the UK Government changes its medical cannabis export rules.
- Medical
Oral cannabis solution relaunched by Tilray in Ireland
The development gives Irish patients greater access to medical cannabis.
- Press releases
Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program
PRESS RELEASE TILRAY Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that it has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP).
- Pharmaceutical
Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses
AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released their latest financial figures.
